Playback speed
10 seconds
ASCO 2021 Highlights on Molecularly Targeted Agents and Tumor Biology: HER2/HER3 Therapies, RAS/RAF Pathway, DNA Damage Repair, Immune Therapy
258 views
July 6, 2021
Login to view comments.
Click here to Login